Farther Finance Advisors, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1992825 SAN FRANCISCO, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$8,528,739

+$1,618,218 QoQ

Shares Held

148,017

+29.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#93

of 1,032 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. BMY ranks #7 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co This page	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,528,739	148,017	+29.9%	Shares	Sole	2026-07-17
2026-03-31	$6,910,521	113,941	+45.6%	Shares	Sole	2026-04-07
2025-12-31	$4,222,585	78,283	+108.6%	Shares	Sole	2026-01-23
2025-09-30	$1,692,467	37,527	+8.9%	Shares	Sole	2025-10-14
2025-06-30	$1,594,644	34,449	-4.1%	Shares	Sole	2025-07-11
2025-03-31	$2,190,272	35,912	+59.3%	Shares	Sole	2025-04-14
2024-12-31	$1,274,862	22,540	-45.8%	Shares	Sole	2025-02-10
2024-09-30	$2,150,935	41,572	+11.9%	Shares	Sole	2024-10-29
2024-06-30	$1,542,258	37,136	+2.1%	Shares	Sole	2024-07-31
2024-03-31	$1,972,019	36,364	+21.1%	Shares	Sole	2024-05-14
2023-12-31	$1,540,223	30,018	+16.3%	Shares	Sole	2024-02-15
2023-09-30	$1,497,432	25,800	+31.3%	Shares	Sole	2023-11-14
2023-06-30	$1,256,809	19,653	+325.7%	Shares	Sole	2024-05-14
2023-03-31	$320,004	4,617	+162.6%	Shares	Sole	2024-05-14
2022-12-31	$126,488	1,758	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.